Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.08425941 |
2 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.71549936 |
3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.67537330 |
4 | negative regulation of cell killing (GO:0031342) | 4.67537330 |
5 | cytoplasmic mRNA processing body assembly (GO:0033962) | 4.61147594 |
6 | positive thymic T cell selection (GO:0045059) | 4.41876655 |
7 | regulation of gamma-delta T cell activation (GO:0046643) | 4.22629896 |
8 | positive regulation of histone deacetylation (GO:0031065) | 4.22106432 |
9 | negative T cell selection (GO:0043383) | 4.13097724 |
10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.08927875 |
11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.08927875 |
12 | negative thymic T cell selection (GO:0045060) | 3.99181438 |
13 | mitotic sister chromatid cohesion (GO:0007064) | 3.98123413 |
14 | positive T cell selection (GO:0043368) | 3.97786099 |
15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.94991692 |
16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.94991692 |
17 | modulation by symbiont of host immune response (GO:0052553) | 3.94991692 |
18 | positive regulation by symbiont of host defense response (GO:0052509) | 3.94991692 |
19 | modulation by symbiont of host defense response (GO:0052031) | 3.94991692 |
20 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.94991692 |
21 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.91189924 |
22 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.88902141 |
23 | thymic T cell selection (GO:0045061) | 3.83732721 |
24 | T cell selection (GO:0045058) | 3.70027816 |
25 | cellular response to interleukin-15 (GO:0071350) | 3.48689475 |
26 | negative regulation of histone methylation (GO:0031061) | 3.46445377 |
27 | negative regulation of T cell mediated immunity (GO:0002710) | 3.34723557 |
28 | macrophage activation involved in immune response (GO:0002281) | 3.33347071 |
29 | histone H3-K4 trimethylation (GO:0080182) | 3.28594711 |
30 | neutrophil activation involved in immune response (GO:0002283) | 3.28420700 |
31 | pre-miRNA processing (GO:0031054) | 3.25396037 |
32 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.24281574 |
33 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.22657405 |
34 | protein localization to endosome (GO:0036010) | 3.20377228 |
35 | interferon-gamma production (GO:0032609) | 3.19487922 |
36 | tolerance induction (GO:0002507) | 3.19312304 |
37 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.18680007 |
38 | mRNA stabilization (GO:0048255) | 3.18674548 |
39 | RNA stabilization (GO:0043489) | 3.18674548 |
40 | detection of other organism (GO:0098543) | 3.17964425 |
41 | histone H3-K36 demethylation (GO:0070544) | 3.17213708 |
42 | hepatocyte apoptotic process (GO:0097284) | 3.16576409 |
43 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.15141636 |
44 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.15060480 |
45 | regulation of RNA export from nucleus (GO:0046831) | 3.11911304 |
46 | nuclear pore complex assembly (GO:0051292) | 3.11837586 |
47 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 3.04911109 |
48 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.02657512 |
49 | positive regulation of protein deacetylation (GO:0090312) | 3.01878865 |
50 | response to interleukin-15 (GO:0070672) | 3.01447420 |
51 | NLS-bearing protein import into nucleus (GO:0006607) | 3.01394248 |
52 | response to muramyl dipeptide (GO:0032495) | 3.00850479 |
53 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.98859966 |
54 | response to peptidoglycan (GO:0032494) | 2.98232461 |
55 | positive regulation of B cell differentiation (GO:0045579) | 2.97453921 |
56 | B cell receptor signaling pathway (GO:0050853) | 2.96529437 |
57 | definitive hemopoiesis (GO:0060216) | 2.96208416 |
58 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.96076797 |
59 | detection of bacterium (GO:0016045) | 2.95537427 |
60 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.94303139 |
61 | nuclear pore organization (GO:0006999) | 2.91007596 |
62 | peptidyl-lysine dimethylation (GO:0018027) | 2.89388861 |
63 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.88871699 |
64 | response to host immune response (GO:0052572) | 2.88871699 |
65 | leukocyte aggregation (GO:0070486) | 2.88277186 |
66 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.85820156 |
67 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.85820156 |
68 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.84465370 |
69 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.83571132 |
70 | peptidyl-lysine trimethylation (GO:0018023) | 2.82240321 |
71 | natural killer cell differentiation (GO:0001779) | 2.81815056 |
72 | T cell costimulation (GO:0031295) | 2.81496831 |
73 | histone H3-K9 demethylation (GO:0033169) | 2.78582487 |
74 | corticosteroid receptor signaling pathway (GO:0031958) | 2.78482115 |
75 | regulation of granulocyte differentiation (GO:0030852) | 2.78079924 |
76 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.78045825 |
77 | microglial cell activation (GO:0001774) | 2.75078523 |
78 | growth hormone receptor signaling pathway (GO:0060396) | 2.74885056 |
79 | lymphocyte costimulation (GO:0031294) | 2.74282257 |
80 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.73018938 |
81 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.72719491 |
82 | regulation of T cell tolerance induction (GO:0002664) | 2.72365427 |
83 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.71702957 |
84 | negative regulation of interleukin-12 production (GO:0032695) | 2.70575685 |
85 | immunoglobulin mediated immune response (GO:0016064) | 2.69327638 |
86 | positive regulation of humoral immune response (GO:0002922) | 2.68979843 |
87 | positive regulation of mRNA catabolic process (GO:0061014) | 2.68917787 |
88 | myeloid cell activation involved in immune response (GO:0002275) | 2.68914303 |
89 | neutrophil activation (GO:0042119) | 2.68887680 |
90 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.68719259 |
91 | response to host (GO:0075136) | 2.68719259 |
92 | response to host defenses (GO:0052200) | 2.68719259 |
93 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.68691954 |
94 | regulation of DNA methylation (GO:0044030) | 2.68499434 |
95 | detection of molecule of bacterial origin (GO:0032490) | 2.67703164 |
96 | detection of external biotic stimulus (GO:0098581) | 2.66774198 |
97 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.66545114 |
98 | germinal center formation (GO:0002467) | 2.66073438 |
99 | regulation of B cell differentiation (GO:0045577) | 2.64987828 |
100 | Peyers patch development (GO:0048541) | 2.64032318 |
101 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.64032318 |
102 | regulation of mRNA stability (GO:0043488) | 2.63765574 |
103 | T cell receptor signaling pathway (GO:0050852) | 2.63223207 |
104 | regulation of histone deacetylation (GO:0031063) | 2.62302904 |
105 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.60974204 |
106 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.60974204 |
107 | regulation of histone H3-K9 methylation (GO:0051570) | 2.60673525 |
108 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.58510150 |
109 | N-terminal protein amino acid acetylation (GO:0006474) | 2.57599722 |
110 | T cell homeostasis (GO:0043029) | 2.56569031 |
111 | regulation of mRNA catabolic process (GO:0061013) | 2.55469213 |
112 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.55228046 |
113 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.54915122 |
114 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.54915122 |
115 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.54915122 |
116 | positive regulation of Rap GTPase activity (GO:0032854) | 2.53519475 |
117 | defense response to protozoan (GO:0042832) | 2.53039968 |
118 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.50273023 |
119 | histone lysine demethylation (GO:0070076) | 2.50021709 |
120 | regulation of RNA stability (GO:0043487) | 2.49971571 |
121 | regulation of protein deacetylation (GO:0090311) | 2.47993172 |
122 | negative regulation of phagocytosis (GO:0050765) | 2.47709188 |
123 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.46621134 |
124 | T cell migration (GO:0072678) | 2.46260798 |
125 | positive regulation of interleukin-2 production (GO:0032743) | 2.43335084 |
126 | cellular extravasation (GO:0045123) | 2.43174179 |
127 | activated T cell proliferation (GO:0050798) | 2.42859835 |
128 | lymphocyte homeostasis (GO:0002260) | 2.41559790 |
129 | negative regulation of B cell proliferation (GO:0030889) | 2.37369611 |
130 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.36644245 |
131 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.36217125 |
132 | histone H2A monoubiquitination (GO:0035518) | 2.34197767 |
133 | negative regulation of granulocyte differentiation (GO:0030853) | 2.33263781 |
134 | germ cell migration (GO:0008354) | 2.31745061 |
135 | B cell homeostasis (GO:0001782) | 2.29980742 |
136 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.29968842 |
137 | histone H3-K4 methylation (GO:0051568) | 2.29405024 |
138 | positive regulation of granulocyte differentiation (GO:0030854) | 2.28955947 |
139 | embryonic process involved in female pregnancy (GO:0060136) | 2.28796970 |
140 | cellular response to growth hormone stimulus (GO:0071378) | 2.28170140 |
141 | histone demethylation (GO:0016577) | 2.27761800 |
142 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.27323766 |
143 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.27323766 |
144 | response to laminar fluid shear stress (GO:0034616) | 2.25345578 |
145 | cortical actin cytoskeleton organization (GO:0030866) | 2.24822409 |
146 | histone mRNA catabolic process (GO:0071044) | 2.24262546 |
147 | megakaryocyte development (GO:0035855) | 2.23087454 |
148 | mitotic chromosome condensation (GO:0007076) | 2.22670586 |
149 | negative regulation of histone modification (GO:0031057) | 2.22537627 |
150 | V(D)J recombination (GO:0033151) | 2.21099915 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.07196234 |
2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.91090437 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.51337675 |
4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.47531278 |
5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.42773454 |
6 | MYC_22102868_ChIP-Seq_BL_Human | 4.10447643 |
7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.61878819 |
8 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.82960044 |
9 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.82689092 |
10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.75591594 |
11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.69249013 |
12 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.56273377 |
13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.56003467 |
14 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.55716221 |
15 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.46095198 |
16 | * MAF_26560356_Chip-Seq_TH1_Human | 2.39153708 |
17 | MYB_26560356_Chip-Seq_TH2_Human | 2.37109326 |
18 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.35580193 |
19 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.34727012 |
20 | * MYB_26560356_Chip-Seq_TH1_Human | 2.25133084 |
21 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.23382250 |
22 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.22758581 |
23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.22486055 |
24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.10104499 |
25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.08728204 |
26 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.08520302 |
27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.04569753 |
28 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.90495885 |
29 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.88484894 |
30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.88155683 |
31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.80353956 |
32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.77810686 |
33 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.74201341 |
34 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.68561874 |
35 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.67971068 |
36 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.64073126 |
37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.62349357 |
38 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.57066625 |
39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.55629021 |
40 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.55156841 |
41 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.49623878 |
42 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.48475772 |
43 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.48120728 |
44 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.45764504 |
45 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.44286320 |
46 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.43746601 |
47 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.41280150 |
48 | GATA3_26560356_Chip-Seq_TH2_Human | 1.38106310 |
49 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36607510 |
50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.34458155 |
51 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.33816800 |
52 | * MAF_26560356_Chip-Seq_TH2_Human | 1.33804090 |
53 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.33178869 |
54 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.32989073 |
55 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31201040 |
56 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.27909944 |
57 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.27755348 |
58 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.27635107 |
59 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.26543797 |
60 | * PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.24060669 |
61 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.23226353 |
62 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.20499714 |
63 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.19571824 |
64 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.19119121 |
65 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19093974 |
66 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16809398 |
67 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.16002947 |
68 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.15931824 |
69 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.15714809 |
70 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.14511903 |
71 | * FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.14424551 |
72 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.10447698 |
73 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10031965 |
74 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.09085931 |
75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08292016 |
76 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.08280944 |
77 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.06357861 |
78 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06197871 |
79 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.05740807 |
80 | KDM2B_26808549_Chip-Seq_K562_Human | 1.04510093 |
81 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.04370294 |
82 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.03648288 |
83 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02681857 |
84 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01630060 |
85 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.01529838 |
86 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98651223 |
87 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.98636633 |
88 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.97466885 |
89 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.97396358 |
90 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97153966 |
91 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96196747 |
92 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.95477416 |
93 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.93954218 |
94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93674165 |
95 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93506144 |
96 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.93500468 |
97 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.93482938 |
98 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91323012 |
99 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.91152684 |
100 | GATA3_26560356_Chip-Seq_TH1_Human | 0.90812225 |
101 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.90097415 |
102 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.90097415 |
103 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.90097415 |
104 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.88708219 |
105 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87108910 |
106 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.86613909 |
107 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.86248286 |
108 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.86246627 |
109 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.84659674 |
110 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.83701042 |
111 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83552833 |
112 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.83139200 |
113 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.79898690 |
114 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77871161 |
115 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.77319075 |
116 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.77226042 |
117 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.76873136 |
118 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.76358090 |
119 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.76180419 |
120 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.75051249 |
121 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.73635280 |
122 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.71349341 |
123 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.69890597 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003300_gastrointestinal_ulcer | 3.90732016 |
2 | MP0003303_peritoneal_inflammation | 3.70955538 |
3 | MP0005076_abnormal_cell_differentiation | 2.95466536 |
4 | MP0003763_abnormal_thymus_physiology | 2.91187116 |
5 | MP0002166_altered_tumor_susceptibility | 2.66957517 |
6 | MP0001800_abnormal_humoral_immune | 2.63627660 |
7 | MP0010352_gastrointestinal_tract_polyps | 2.56514434 |
8 | MP0000685_abnormal_immune_system | 2.40747931 |
9 | MP0002396_abnormal_hematopoietic_system | 2.39733851 |
10 | MP0004808_abnormal_hematopoietic_stem | 2.38295639 |
11 | MP0005387_immune_system_phenotype | 2.35081475 |
12 | MP0001790_abnormal_immune_system | 2.35081475 |
13 | MP0010234_abnormal_vibrissa_follicle | 2.27658248 |
14 | MP0009278_abnormal_bone_marrow | 2.24908067 |
15 | MP0002398_abnormal_bone_marrow | 2.21010359 |
16 | MP0005671_abnormal_response_to | 2.17444725 |
17 | MP0002006_tumorigenesis | 2.08796413 |
18 | MP0001835_abnormal_antigen_presentation | 2.08383097 |
19 | MP0000703_abnormal_thymus_morphology | 2.07806078 |
20 | MP0002452_abnormal_antigen_presenting | 2.01805627 |
21 | MP0008877_abnormal_DNA_methylation | 1.98170561 |
22 | MP0002723_abnormal_immune_serum | 1.91349971 |
23 | MP0002420_abnormal_adaptive_immunity | 1.91297721 |
24 | MP0010307_abnormal_tumor_latency | 1.90299408 |
25 | MP0005000_abnormal_immune_tolerance | 1.89757540 |
26 | MP0001819_abnormal_immune_cell | 1.87853807 |
27 | MP0004381_abnormal_hair_follicle | 1.87585415 |
28 | MP0004510_myositis | 1.86917765 |
29 | MP0003705_abnormal_hypodermis_morpholog | 1.85245156 |
30 | MP0008961_abnormal_basal_metabolism | 1.82312964 |
31 | MP0003436_decreased_susceptibility_to | 1.82047927 |
32 | MP0000569_abnormal_digit_pigmentation | 1.82000691 |
33 | MP0000716_abnormal_immune_system | 1.80865254 |
34 | MP0002722_abnormal_immune_system | 1.76239433 |
35 | MP0002405_respiratory_system_inflammati | 1.75883283 |
36 | MP0000689_abnormal_spleen_morphology | 1.75709122 |
37 | MP0004947_skin_inflammation | 1.72004363 |
38 | MP0010155_abnormal_intestine_physiology | 1.71324238 |
39 | MP0004185_abnormal_adipocyte_glucose | 1.66148386 |
40 | MP0003656_abnormal_erythrocyte_physiolo | 1.64330956 |
41 | MP0001873_stomach_inflammation | 1.63863903 |
42 | MP0001545_abnormal_hematopoietic_system | 1.63454484 |
43 | MP0005397_hematopoietic_system_phenotyp | 1.63454484 |
44 | MP0002429_abnormal_blood_cell | 1.50114113 |
45 | MP0005025_abnormal_response_to | 1.39824397 |
46 | MP0003866_abnormal_defecation | 1.39530717 |
47 | MP0005075_abnormal_melanosome_morpholog | 1.37051631 |
48 | MP0005464_abnormal_platelet_physiology | 1.36584277 |
49 | MP0003091_abnormal_cell_migration | 1.36184472 |
50 | MP0009333_abnormal_splenocyte_physiolog | 1.33629923 |
51 | MP0002148_abnormal_hypersensitivity_rea | 1.32029156 |
52 | MP0002009_preneoplasia | 1.31916006 |
53 | MP0000465_gastrointestinal_hemorrhage | 1.30605570 |
54 | MP0003221_abnormal_cardiomyocyte_apopto | 1.29630955 |
55 | MP0002419_abnormal_innate_immunity | 1.29377757 |
56 | MP0000490_abnormal_crypts_of | 1.26198245 |
57 | MP0001853_heart_inflammation | 1.26160299 |
58 | MP0001845_abnormal_inflammatory_respons | 1.25638599 |
59 | MP0005310_abnormal_salivary_gland | 1.23868233 |
60 | MP0002138_abnormal_hepatobiliary_system | 1.22366622 |
61 | MP0003566_abnormal_cell_adhesion | 1.20604342 |
62 | MP0008057_abnormal_DNA_replication | 1.16359622 |
63 | MP0005451_abnormal_body_composition | 1.14409028 |
64 | MP0001849_ear_inflammation | 1.13493645 |
65 | MP0003172_abnormal_lysosome_physiology | 1.12523045 |
66 | MP0002877_abnormal_melanocyte_morpholog | 1.09871103 |
67 | MP0008260_abnormal_autophagy | 1.09482457 |
68 | MP0000733_abnormal_muscle_development | 1.08822727 |
69 | MP0002086_abnormal_extraembryonic_tissu | 1.08725292 |
70 | MP0002277_abnormal_respiratory_mucosa | 1.08475264 |
71 | MP0000015_abnormal_ear_pigmentation | 1.07779261 |
72 | MP0003045_fibrosis | 1.07468362 |
73 | MP0003448_altered_tumor_morphology | 1.05242836 |
74 | MP0000350_abnormal_cell_proliferation | 1.03380199 |
75 | MP0006082_CNS_inflammation | 1.02561453 |
76 | MP0003077_abnormal_cell_cycle | 1.01934436 |
77 | MP0010094_abnormal_chromosome_stability | 1.01907873 |
78 | MP0001851_eye_inflammation | 1.00229683 |
79 | MP0008058_abnormal_DNA_repair | 0.99768455 |
80 | MP0009785_altered_susceptibility_to | 0.98287312 |
81 | MP0002019_abnormal_tumor_incidence | 0.97672270 |
82 | MP0003183_abnormal_peptide_metabolism | 0.95356925 |
83 | MP0002132_abnormal_respiratory_system | 0.93830000 |
84 | MP0002928_abnormal_bile_duct | 0.93756927 |
85 | MP0001915_intracranial_hemorrhage | 0.93018682 |
86 | MP0003828_pulmonary_edema | 0.89655480 |
87 | MP0003453_abnormal_keratinocyte_physiol | 0.88568780 |
88 | MP0003252_abnormal_bile_duct | 0.88343003 |
89 | MP0004264_abnormal_extraembryonic_tissu | 0.87312791 |
90 | MP0002088_abnormal_embryonic_growth/wei | 0.86379231 |
91 | MP0003984_embryonic_growth_retardation | 0.85969642 |
92 | MP0002925_abnormal_cardiovascular_devel | 0.85706130 |
93 | MP0003890_abnormal_embryonic-extraembry | 0.84945692 |
94 | MP0005666_abnormal_adipose_tissue | 0.84138487 |
95 | MP0003787_abnormal_imprinting | 0.83800525 |
96 | MP0003943_abnormal_hepatobiliary_system | 0.82278841 |
97 | MP0010678_abnormal_skin_adnexa | 0.80800143 |
98 | MP0001533_abnormal_skeleton_physiology | 0.80295750 |
99 | MP0009115_abnormal_fat_cell | 0.80061952 |
100 | MP0001730_embryonic_growth_arrest | 0.79313207 |
101 | MP0001672_abnormal_embryogenesis/_devel | 0.79281083 |
102 | MP0005380_embryogenesis_phenotype | 0.79281083 |
103 | MP0003724_increased_susceptibility_to | 0.79179225 |
104 | MP0005174_abnormal_tail_pigmentation | 0.79109377 |
105 | MP0000609_abnormal_liver_physiology | 0.79089949 |
106 | MP0004197_abnormal_fetal_growth/weight/ | 0.78367336 |
107 | MP0008469_abnormal_protein_level | 0.76614417 |
108 | MP0005621_abnormal_cell_physiology | 0.75412287 |
109 | MP0000858_altered_metastatic_potential | 0.74484114 |
110 | MP0005023_abnormal_wound_healing | 0.74363307 |
111 | MP0009703_decreased_birth_body | 0.73868931 |
112 | MP0000313_abnormal_cell_death | 0.73680242 |
113 | MP0002998_abnormal_bone_remodeling | 0.73677515 |
114 | MP0002933_joint_inflammation | 0.71908673 |
115 | MP0002971_abnormal_brown_adipose | 0.71316224 |
116 | MP0003111_abnormal_nucleus_morphology | 0.71284124 |
117 | MP0004883_abnormal_blood_vessel | 0.70957135 |
118 | MP0009672_abnormal_birth_weight | 0.70869095 |
119 | MP0003191_abnormal_cellular_cholesterol | 0.70822920 |
120 | MP0006054_spinal_hemorrhage | 0.70134731 |
121 | MP0005375_adipose_tissue_phenotype | 0.68598252 |
122 | MP0003693_abnormal_embryo_hatching | 0.61042890 |
123 | MP0003699_abnormal_female_reproductive | 0.58396671 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of the fingertips (HP:0001211) | 4.57312660 |
2 | T lymphocytopenia (HP:0005403) | 3.88791027 |
3 | Abnormality of T cell number (HP:0011839) | 3.68709531 |
4 | Recurrent viral infections (HP:0004429) | 3.59071698 |
5 | Hematochezia (HP:0002573) | 3.37269105 |
6 | Recurrent fungal infections (HP:0002841) | 3.02883127 |
7 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.99412016 |
8 | Recurrent skin infections (HP:0001581) | 2.96656348 |
9 | Spontaneous hematomas (HP:0007420) | 2.95661483 |
10 | Volvulus (HP:0002580) | 2.95478865 |
11 | Optic neuritis (HP:0100653) | 2.94213062 |
12 | Retrobulbar optic neuritis (HP:0100654) | 2.94213062 |
13 | Abnormality of B cell number (HP:0010975) | 2.93796926 |
14 | B lymphocytopenia (HP:0010976) | 2.93796926 |
15 | Encephalitis (HP:0002383) | 2.90710699 |
16 | Panhypogammaglobulinemia (HP:0003139) | 2.87013226 |
17 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.85768153 |
18 | Gastrointestinal infarctions (HP:0005244) | 2.82740832 |
19 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.80392026 |
20 | Abnormality of macrophages (HP:0004311) | 2.76289247 |
21 | Orchitis (HP:0100796) | 2.75288501 |
22 | Acute lymphatic leukemia (HP:0006721) | 2.70401082 |
23 | Thyroiditis (HP:0100646) | 2.69291935 |
24 | Macroorchidism (HP:0000053) | 2.68064742 |
25 | Osteomyelitis (HP:0002754) | 2.67892060 |
26 | Autoimmune thrombocytopenia (HP:0001973) | 2.66119449 |
27 | Inflammation of the large intestine (HP:0002037) | 2.65498601 |
28 | Colitis (HP:0002583) | 2.65455499 |
29 | Verrucae (HP:0200043) | 2.64209581 |
30 | Papilloma (HP:0012740) | 2.64209581 |
31 | Papillary thyroid carcinoma (HP:0002895) | 2.63049624 |
32 | Abnormality of T cells (HP:0002843) | 2.60868629 |
33 | Gastrointestinal inflammation (HP:0004386) | 2.55713714 |
34 | Chronic otitis media (HP:0000389) | 2.55564162 |
35 | Cellulitis (HP:0100658) | 2.53222165 |
36 | Hypochromic microcytic anemia (HP:0004840) | 2.50752665 |
37 | Gingivitis (HP:0000230) | 2.46135062 |
38 | Eczematoid dermatitis (HP:0000976) | 2.44115997 |
39 | Recurrent bronchitis (HP:0002837) | 2.43401947 |
40 | Long eyelashes (HP:0000527) | 2.43302373 |
41 | IgM deficiency (HP:0002850) | 2.42219025 |
42 | Keratoconjunctivitis sicca (HP:0001097) | 2.41573802 |
43 | Cerebral aneurysm (HP:0004944) | 2.37817118 |
44 | Increased density of long bones (HP:0006392) | 2.37496808 |
45 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.34329521 |
46 | Nasal polyposis (HP:0100582) | 2.33357434 |
47 | Agammaglobulinemia (HP:0004432) | 2.28488549 |
48 | Amaurosis fugax (HP:0100576) | 2.25222484 |
49 | Lymphoma (HP:0002665) | 2.21428111 |
50 | Keratoconjunctivitis (HP:0001096) | 2.20922702 |
51 | Eosinophilia (HP:0001880) | 2.19368886 |
52 | Increased IgE level (HP:0003212) | 2.19070367 |
53 | Abnormal hair whorl (HP:0010721) | 2.18872812 |
54 | Meningitis (HP:0001287) | 2.18102470 |
55 | Aortic aneurysm (HP:0004942) | 2.16439257 |
56 | Urethral obstruction (HP:0000796) | 2.15418641 |
57 | Chronic obstructive pulmonary disease (HP:0006510) | 2.14889939 |
58 | Obstructive lung disease (HP:0006536) | 2.14889939 |
59 | Recurrent cutaneous fungal infections (HP:0011370) | 2.14382470 |
60 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.14382470 |
61 | Hyperacusis (HP:0010780) | 2.13600425 |
62 | Combined immunodeficiency (HP:0005387) | 2.12886908 |
63 | Abnormality of the nasal mucosa (HP:0000433) | 2.12744277 |
64 | Severe combined immunodeficiency (HP:0004430) | 2.11579648 |
65 | Short 4th metacarpal (HP:0010044) | 2.10883460 |
66 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.10883460 |
67 | Hypochromic anemia (HP:0001931) | 2.08555308 |
68 | Narrow palate (HP:0000189) | 2.08144320 |
69 | Rectal prolapse (HP:0002035) | 2.08080752 |
70 | Mitral valve prolapse (HP:0001634) | 2.07571326 |
71 | Subacute progressive viral hepatitis (HP:0006572) | 2.07471293 |
72 | Arterial thrombosis (HP:0004420) | 2.07344383 |
73 | Urticaria (HP:0001025) | 2.05353889 |
74 | Sandal gap (HP:0001852) | 2.04707899 |
75 | Heterotopia (HP:0002282) | 2.04543760 |
76 | Slow saccadic eye movements (HP:0000514) | 2.04326204 |
77 | Persistence of primary teeth (HP:0006335) | 2.03099232 |
78 | Myositis (HP:0100614) | 1.99757957 |
79 | Cutis marmorata (HP:0000965) | 1.99398041 |
80 | Dysmetric saccades (HP:0000641) | 1.99212181 |
81 | Truncal obesity (HP:0001956) | 1.98982664 |
82 | Hemoptysis (HP:0002105) | 1.97574705 |
83 | Basal cell carcinoma (HP:0002671) | 1.95909933 |
84 | Acute myeloid leukemia (HP:0004808) | 1.94719926 |
85 | Pulmonary infiltrates (HP:0002113) | 1.92541171 |
86 | Myocardial infarction (HP:0001658) | 1.92343168 |
87 | Abnormal platelet volume (HP:0011876) | 1.92314724 |
88 | Abnormality of chromosome segregation (HP:0002916) | 1.91581964 |
89 | Lymphopenia (HP:0001888) | 1.91237967 |
90 | Chest pain (HP:0100749) | 1.90673112 |
91 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.89277686 |
92 | Papilledema (HP:0001085) | 1.88376536 |
93 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.87994171 |
94 | Absent frontal sinuses (HP:0002688) | 1.87795109 |
95 | Prolonged bleeding time (HP:0003010) | 1.87666318 |
96 | Pseudobulbar signs (HP:0002200) | 1.87495478 |
97 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.87477211 |
98 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.87084936 |
99 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.86353867 |
100 | Gastrointestinal carcinoma (HP:0002672) | 1.86353867 |
101 | Abnormality of eosinophils (HP:0001879) | 1.85923142 |
102 | Sepsis (HP:0100806) | 1.85773943 |
103 | Fair hair (HP:0002286) | 1.85417933 |
104 | Stomatitis (HP:0010280) | 1.85415514 |
105 | Periodontitis (HP:0000704) | 1.83516496 |
106 | Recurrent bacterial skin infections (HP:0005406) | 1.82456736 |
107 | Viral hepatitis (HP:0006562) | 1.82280083 |
108 | Prominent nose (HP:0000448) | 1.82199276 |
109 | Vertebral arch anomaly (HP:0008438) | 1.81821955 |
110 | Vasculitis (HP:0002633) | 1.81274061 |
111 | Epistaxis (HP:0000421) | 1.80635006 |
112 | Microcytic anemia (HP:0001935) | 1.80288391 |
113 | Fatigue (HP:0012378) | 1.78853761 |
114 | Disproportionate tall stature (HP:0001519) | 1.78520731 |
115 | High pitched voice (HP:0001620) | 1.77684525 |
116 | Abnormality of T cell physiology (HP:0011840) | 1.77619622 |
117 | Autoimmune hemolytic anemia (HP:0001890) | 1.76542553 |
118 | Recurrent abscess formation (HP:0002722) | 1.75835219 |
119 | Leukocytosis (HP:0001974) | 1.75652748 |
120 | Increased nuchal translucency (HP:0010880) | 1.75369650 |
121 | Bladder carcinoma (HP:0002862) | 1.75062152 |
122 | Bladder neoplasm (HP:0009725) | 1.75062152 |
123 | Pustule (HP:0200039) | 1.74769599 |
124 | Disinhibition (HP:0000734) | 1.74357859 |
125 | Hypoplasia of the thymus (HP:0000778) | 1.72029555 |
126 | Low anterior hairline (HP:0000294) | 1.71235756 |
127 | Granulocytopenia (HP:0001913) | 1.70347956 |
128 | Spinal cord lesions (HP:0100561) | 1.69421794 |
129 | Syringomyelia (HP:0003396) | 1.69421794 |
130 | Mediastinal lymphadenopathy (HP:0100721) | 1.68701159 |
131 | Gingival bleeding (HP:0000225) | 1.67919610 |
132 | IgA deficiency (HP:0002720) | 1.66090972 |
133 | Abnormality of oral frenula (HP:0000190) | 1.64804373 |
134 | Thrombocytosis (HP:0001894) | 1.64757095 |
135 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.63751686 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 3.59988957 |
2 | CDK12 | 3.47147348 |
3 | RIPK4 | 3.36136441 |
4 | MAP3K10 | 3.07566958 |
5 | EEF2K | 3.03192498 |
6 | PRPF4B | 2.88130660 |
7 | TRIB3 | 2.42222800 |
8 | STK10 | 2.40204878 |
9 | PKN2 | 2.30501753 |
10 | GRK6 | 2.08023019 |
11 | IRAK4 | 1.94124039 |
12 | FGFR3 | 1.90902837 |
13 | TYK2 | 1.90055927 |
14 | YES1 | 1.89916531 |
15 | TXK | 1.83179202 |
16 | PTK6 | 1.76590611 |
17 | JAK3 | 1.76482622 |
18 | JAK1 | 1.65123537 |
19 | SIK2 | 1.61124765 |
20 | CAMK1D | 1.60955223 |
21 | ITK | 1.60571833 |
22 | CAMK1G | 1.57802304 |
23 | CDK6 | 1.54559518 |
24 | TAOK3 | 1.52858389 |
25 | TNK2 | 1.51904932 |
26 | LATS1 | 1.51590040 |
27 | FGFR4 | 1.51000240 |
28 | IRAK2 | 1.48119486 |
29 | TGFBR2 | 1.46121027 |
30 | MELK | 1.38335290 |
31 | IRAK1 | 1.35860550 |
32 | SIK3 | 1.34518561 |
33 | ALK | 1.34058171 |
34 | ZAP70 | 1.32919148 |
35 | LRRK2 | 1.30426543 |
36 | HIPK2 | 1.27608821 |
37 | MAP3K1 | 1.26127573 |
38 | PIM1 | 1.22649333 |
39 | DMPK | 1.22459462 |
40 | EPHB1 | 1.20878657 |
41 | RPS6KA4 | 1.20487602 |
42 | CDK9 | 1.18520910 |
43 | CSK | 1.17876599 |
44 | CDK4 | 1.16538904 |
45 | HCK | 1.16522890 |
46 | JAK2 | 1.16236517 |
47 | BTK | 1.15412272 |
48 | STK3 | 1.15241002 |
49 | NEK2 | 1.13307116 |
50 | BRD4 | 1.12121575 |
51 | IKBKE | 1.10212970 |
52 | BLK | 1.08539717 |
53 | TAOK1 | 1.07904320 |
54 | MARK3 | 1.04585119 |
55 | NLK | 1.03468244 |
56 | RAF1 | 1.03030085 |
57 | RIPK1 | 1.01861566 |
58 | PASK | 1.01080184 |
59 | FGFR2 | 0.97874031 |
60 | CDC7 | 0.96505128 |
61 | LYN | 0.96461001 |
62 | SGK3 | 0.96410720 |
63 | MAP3K14 | 0.94947075 |
64 | SIK1 | 0.94934349 |
65 | WNK1 | 0.93963688 |
66 | SMG1 | 0.93810007 |
67 | NEK6 | 0.93423075 |
68 | PRKCH | 0.93385067 |
69 | PDGFRB | 0.91381415 |
70 | LCK | 0.91371069 |
71 | FES | 0.91254058 |
72 | CSF1R | 0.87807225 |
73 | BMPR2 | 0.87592691 |
74 | CHUK | 0.86991113 |
75 | SYK | 0.86474687 |
76 | MAP3K7 | 0.86245455 |
77 | FRK | 0.85757076 |
78 | ERN1 | 0.85611761 |
79 | KSR1 | 0.85569922 |
80 | STK4 | 0.84412324 |
81 | MAP3K13 | 0.83262552 |
82 | MTOR | 0.80466294 |
83 | RET | 0.80100036 |
84 | PRKD2 | 0.79072795 |
85 | MAP2K3 | 0.78695590 |
86 | TEC | 0.78667636 |
87 | TTN | 0.77928933 |
88 | AKT3 | 0.75085019 |
89 | MAPK7 | 0.72072731 |
90 | PDK1 | 0.71026390 |
91 | FGR | 0.70980847 |
92 | CAMKK2 | 0.70964457 |
93 | STK11 | 0.68823859 |
94 | PDGFRA | 0.68774865 |
95 | MAP3K8 | 0.68636707 |
96 | TYRO3 | 0.68506775 |
97 | STK24 | 0.66997760 |
98 | TBK1 | 0.66970594 |
99 | SCYL2 | 0.66125245 |
100 | MAPK12 | 0.60556086 |
101 | MAP3K3 | 0.59369621 |
102 | MKNK2 | 0.59151011 |
103 | BRSK2 | 0.58389030 |
104 | CLK1 | 0.57113744 |
105 | BMX | 0.56205216 |
106 | KIT | 0.55825044 |
107 | IKBKB | 0.55506448 |
108 | MARK2 | 0.54677369 |
109 | CDK3 | 0.54320325 |
110 | SGK2 | 0.52398583 |
111 | CAMKK1 | 0.50501730 |
112 | EPHA3 | 0.47558566 |
113 | RPS6KB2 | 0.47018044 |
114 | MAP3K2 | 0.46427048 |
115 | PIK3CG | 0.45898102 |
116 | NEK9 | 0.44712634 |
117 | ATM | 0.44622625 |
118 | CAMK4 | 0.44465514 |
119 | PRKCQ | 0.44447246 |
120 | TAF1 | 0.44287537 |
121 | EGFR | 0.43138493 |
122 | KSR2 | 0.43084689 |
123 | ATR | 0.42023897 |
124 | SGK223 | 0.41852353 |
125 | SGK494 | 0.41852353 |
126 | STK38 | 0.41140442 |
127 | ACVR1B | 0.40356140 |
128 | CSNK1D | 0.39592600 |
129 | CHEK1 | 0.37961290 |
130 | ABL1 | 0.36651618 |
131 | MAP3K6 | 0.36576185 |
132 | NUAK1 | 0.35320890 |
133 | FGFR1 | 0.35307056 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.47435784 |
2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.35258820 |
3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.02082318 |
4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.94652533 |
5 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.91672314 |
6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.88197433 |
7 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.69022993 |
8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.62140200 |
9 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.61093629 |
10 | Leishmaniasis_Homo sapiens_hsa05140 | 1.58227309 |
11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.58051982 |
12 | Allograft rejection_Homo sapiens_hsa05330 | 1.56776957 |
13 | Measles_Homo sapiens_hsa05162 | 1.53385180 |
14 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.52197724 |
15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.50156530 |
16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.48829382 |
17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.45756313 |
18 | Lysine degradation_Homo sapiens_hsa00310 | 1.44829818 |
19 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.44822092 |
20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.43375318 |
21 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.41707653 |
22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.38740649 |
23 | Hepatitis B_Homo sapiens_hsa05161 | 1.36425046 |
24 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.32070016 |
25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.31747056 |
26 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.27730245 |
27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.27594340 |
28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.26105102 |
29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.24871300 |
30 | Colorectal cancer_Homo sapiens_hsa05210 | 1.23488651 |
31 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.23340069 |
32 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.22503388 |
33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.21192716 |
34 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.20697177 |
35 | Insulin resistance_Homo sapiens_hsa04931 | 1.19830647 |
36 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.19360396 |
37 | Platelet activation_Homo sapiens_hsa04611 | 1.17774523 |
38 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.17494750 |
39 | Endometrial cancer_Homo sapiens_hsa05213 | 1.15822961 |
40 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.15066114 |
41 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.14947725 |
42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.14130844 |
43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13196287 |
44 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.12171941 |
45 | Prostate cancer_Homo sapiens_hsa05215 | 1.10111525 |
46 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.10044256 |
47 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.09688924 |
48 | Viral myocarditis_Homo sapiens_hsa05416 | 1.07794860 |
49 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.06531129 |
50 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.05200968 |
51 | Adherens junction_Homo sapiens_hsa04520 | 1.04573393 |
52 | Influenza A_Homo sapiens_hsa05164 | 1.04404893 |
53 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.03785777 |
54 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.03038203 |
55 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.02439492 |
56 | HTLV-I infection_Homo sapiens_hsa05166 | 1.01047002 |
57 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.00010920 |
58 | Glioma_Homo sapiens_hsa05214 | 0.99908311 |
59 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.96562543 |
60 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.96086267 |
61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.94868097 |
62 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.93193785 |
63 | Apoptosis_Homo sapiens_hsa04210 | 0.91225205 |
64 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.88958220 |
65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.87931323 |
66 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86630960 |
67 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.82843872 |
68 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.81465457 |
69 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.80701575 |
70 | Tuberculosis_Homo sapiens_hsa05152 | 0.80449181 |
71 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.78962778 |
72 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.78695575 |
73 | Asthma_Homo sapiens_hsa05310 | 0.78242373 |
74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75623817 |
75 | Malaria_Homo sapiens_hsa05144 | 0.75286494 |
76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.75083553 |
77 | Hepatitis C_Homo sapiens_hsa05160 | 0.74728849 |
78 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.74276749 |
79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74045243 |
80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.73757156 |
81 | Shigellosis_Homo sapiens_hsa05131 | 0.70765647 |
82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69007764 |
83 | Focal adhesion_Homo sapiens_hsa04510 | 0.68953782 |
84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.68622587 |
85 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.64690287 |
86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64637878 |
87 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64284160 |
88 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.62908308 |
89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62538078 |
90 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.61863722 |
91 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61139211 |
92 | Thyroid cancer_Homo sapiens_hsa05216 | 0.60134907 |
93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59369606 |
94 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.59126274 |
95 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58253312 |
96 | Pathways in cancer_Homo sapiens_hsa05200 | 0.57956869 |
97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57938130 |
98 | Pertussis_Homo sapiens_hsa05133 | 0.55814725 |
99 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55512594 |
100 | RNA degradation_Homo sapiens_hsa03018 | 0.54106102 |
101 | Cell cycle_Homo sapiens_hsa04110 | 0.52556032 |
102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.52303995 |
103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51905036 |
104 | Long-term potentiation_Homo sapiens_hsa04720 | 0.51271792 |
105 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.50798670 |
106 | Amoebiasis_Homo sapiens_hsa05146 | 0.49858009 |
107 | Endocytosis_Homo sapiens_hsa04144 | 0.48809352 |
108 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47629126 |
109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.47424870 |
110 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.47284697 |
111 | Legionellosis_Homo sapiens_hsa05134 | 0.47223916 |
112 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46643025 |
113 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.46584224 |
114 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.45689219 |
115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45526919 |
116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45248319 |
117 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.44660226 |
118 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.44307553 |
119 | Long-term depression_Homo sapiens_hsa04730 | 0.44014616 |